Dr. Reddy's Laboratories Stock Price (NYSE:RDY)

Add to My Stocks
$32.94 $0.22 (0.66%) RDY stock closing price Mar 19, 2018 (Closing)
Prev Close* : $33.16
Market Cap:
Day Low: $32.81
52 Week Low: $29.83
Open: $33.02
Volume: -
Day High: $33.17
52 Week High: $42.97

Latest Stock Market News

Latest Articles

Dr. Reddy's Laboratories News - From Partners

RDY Stockcharts

View RDY PE ratio, PS ratio stocks charts and compare with peers.
RDY Chart
Note: Compare Dr. Reddy's Laboratories stock price history with the index and industry peers.

Dr. Reddy's Laboratories Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Dr. Reddy's Laboratories Returns

(return on equity)

Dr. Reddy's Laboratories Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

RDY Industry Peers

Company Price Change (%)
Teva Pharmaceutical (TEVA)17.910.46 (2.5%)
Aspen Pharmacr (APNHY)21.450.15 (0.7%)
Novartis (NVS)81.230.83 (1.01%)
Sanofi (SNY)40.750.21 (0.51%)
Sanofi (SNY)40.750.21 (0.51%)
Eisai (ESALY)64.810.22 (0.34%)
Curis (CRIS)0.730.01 (1.35%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Teligent (TLGT)3.160.16 (5.33%)
AxoGen (AXGN)37.850.2 (0.53%)
Top gainers from Medical-Generic Drugs industry
* As of Mar 20, 2018
CompanyPriceChange (%)
Mallinckrodt (MNK)15.20.89 (5.53%)
Adamas Pharma (ADMS)26.091.01 (3.73%)
Agile Therapeutics (AGRX)2.920.11 (3.63%)
AEVI GENOMIC (GNMX)1.970.07 (3.43%)
Impax Lab (IPXL)20.450.6 (2.85%)
Teva Pharmaceutical (TEVA)17.910.46 (2.5%)
Mylan (MYL)40.80.93 (2.23%)
Top losers from Medical-Generic Drugs industry
* As of Mar 20, 2018

Dr.Reddy's Laboratories Ltd (ADR) Stock News - Partner Headlines

Dr. Reddy's Laboratories Financial Statements

income statement20172016201520142013
Net Sales or Revenues2.17B2.34B2.38B2.2B2.13B
Net Income186M302M356M359M308M
Total Operating Expense1B946M948M829M757M
View Dr. Reddy's Laboratories income statement
balance sheet20172016201520142013
Total Assets3.39B3.13B3.13B2.84B2.61B
Total Liabilities1.48B1.2B1.34B1.32B1.27B
Shareholders Equity1.91B1.94B1.79B1.51B1.34B
View Dr. Reddy's Laboratories balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-83M-3M-241M-172M-343M
Net Cash from (used by) Operating Activities332M623M402M324M244M
Increase (Decrease) in Prop Plant And Equipment-188M-180M-147M-167M-121M
View Dr. Reddy's Laboratories cash flow statement

Dr. Reddy's Laboratories Stock Message Board

Dr. Reddy's Laboratories stock lost 0.66%, and the last close price as of Mar 19, 2018 is $32.94 for RDY stock. Looking at Dr. Reddy's Laboratories market capitalization, which currently stands at $5.5B, we can say that RDY stock is a Mid Cap stock. Dr. Reddy's Laboratories valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Dr. Reddy's Laboratories is worth a lot, it will most likely be reflected in an inflated Dr. Reddy's Laboratories stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 261,251 on the last trading day, as is evident from Dr. Reddy's Laboratories stock chart, and RDY stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Dr. Reddy's Laboratories stock dividend was 0.29 during the last quarter. One can observe stock price trends and check for volatility by checking Dr. Reddy's Laboratories stock price history.